Basel Medical Group Ltd (BMGL) Financial Statements
Basel Medical Group Ltd (BMGL) files with the U.S. Securities and Exchange Commission under CIK 0002004489. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- 11.32 million SGD
- Net Income
- -10.64 million SGD
- Total Assets
- 18.68 million SGD
- Net Cash from Operations
- -4.04 million SGD
Fiscal year ended Jun 30, 2025. Latest periodic SEC filing: Mar 13, 2026. Source: SEC filings (EDGAR XBRL). Amounts in SGD.
Open the full financial statements for BMGL in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History